The authors of a new report have recommended that vaping products should be primarily regulated in Australia as consumer goods rather than as therapeutic, medicinal or tobacco products.
The report, Legalising Vaping in Australia, was published on Saturday by the McKell Institute, and was the subject of a story posted on the website of the Australian Harm Reduction Association.
In the report’s executive summary, the authors said that ‘legalising vaping has enormous potential to improve public health, particularly for disadvantaged smokers who are disproportionately affected by smoking-related diseases’.
‘We recommend that vaping products should be primarily regulated as consumer goods rather than as a therapeutic, medicinal or tobacco product,’ they said.
‘Regulation should aim to maximise the benefit for adult smokers while reducing any potential risks to users and harm to the wider population, especially young people who have never smoked.
‘Regulation should be proportionate to the risk of vaping.
‘The authors strongly recommend that Australia’s successful tobacco control policy continues and is supplemented by two changes: first, ending the de facto ban on vaping; and second, re-introducing appropriately funded mass media campaigns and supporting counselling to increase quitting rates.’
The McKell Institute is described as an independent, not-for-profit, public policy institute dedicated to developing practical policy ideas and contributing to public debate.
The report’s co-authors are: Dr. Alex Wodak AM, Conjoint Associate Professor Colin Mendelsohn.